Anastrozole Tablets — Class II drug recall D-1394-2019
Terminated recall by American Health Packaging, reported 2019-06-26, distributed nationwide. GMP Deviations: Potential cross contamination due to cleaning procedure failure.
| Recall number | D-1394-2019 |
|---|---|
| Product type | Drug |
| Classification | Class II |
| Status | Terminated |
| Voluntary or mandated | Voluntary |
| Recalling firm | American Health Packaging, Columbus, OH, United States |
| Recall initiated | 2019-05-09 |
| Classified | 2019-06-19 |
| Reported by FDA | 2019-06-26 |
| Terminated | 2020-09-30 |
| Distributed | Nationwide (US) |
| Quantity | 15,386 cartons |
| Reason classes | cgmp |
| NDC | 60687-0112, 60687-0112-11, 60687-0112-21 |
| Lot numbers | 175286B, 175289A, 175290B, 179906A, 183252A, 184611A |
| Expiration dates | 2019-08-31, 2020-03-31, 2020-09-30, 2020-11-30 |
Product
Anastrozole Tablets, USP, 1mg, 30-count unit dose blisters per carton, Rx Only, Packaged and Distributed by: American Health Packaging, Columbus, Ohio 43217. NDC 60687-112-21.
Reason for recall
GMP Deviations: Potential cross contamination due to cleaning procedure failure.
Machine access
This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-1394-2019. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.
Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.